Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study

Lomitapide in the long-term real-world management of HoFH – effectiveness, tolerability, and hepatic safety from the Pan-European study

Bibliographic Details
Main Authors:	J. Cegla, L. d’Erasmo, K. Steward, A. di Costanzo, E. Boersma, M. Arca, J. Roeters van Lennep
Format:	Article
Language:	English
Published:	Elsevier 2022-10-01
Series:	Atherosclerosis Plus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667089522000244

Similar Items

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
by: Laura D’Erasmo, et al.
Published: (2021-09-01)

Case report: Therapy adherence, MTTP variants, and course of atheroma in two patients with HoFH on low-dose, long-term lomitapide therapy
by: Meral Kayikcioglu, et al.
Published: (2023-01-01)

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
by: Walzer S, et al.
Published: (2013-05-01)

Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia
by: J. Cegla, et al.
Published: (2023-12-01)

Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study
by: Laura D’Erasmo, et al.
Published: (2022-08-01)

Lomitapide en hipercolesterolemia familiar heterocigota
by: Juan Esteban Bedoya Loaiza, et al.
Published: (2022-02-01)

Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites
by: Ana Carolina C. de Sousa, et al.
Published: (2020-03-01)

Target achievement and cardiovascular event rates with Lomitapide in homozygous Familial Hypercholesterolaemia
by: Dirk J. Blom, et al.
Published: (2018-06-01)

Xanthomas Regression in an 8-Year-Old Boy Treated With Lomitapide
by: Genovefa Kolovou, MD, PhD, et al.
Published: (2019-10-01)

Efficacy and Safety of Lomitapide in Homozygous Familial Hypercholesterolaemia: A Systematic Review
by: Namin Wei, et al.
Published: (2022-04-01)

The Beneficial Effect of Lomitapide on the Cardiovascular System in LDLr<sup>−/−</sup> Mice with Obesity
by: Undral Munkhsaikhan, et al.
Published: (2023-06-01)

Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus aureus
by: Yufang Zhang, et al.
Published: (2022-04-01)

The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?
by: Simone Bini, et al.
Published: (2021-01-01)

Lomitapide for the treatment of paediatric homozygous familial hypercholesterolaemia patients - Results from the efficacy phase of the APH-19 study
by: L. Masana, et al.
Published: (2023-12-01)

Elevated lipoprotein(a) levels in Familial Hypercholesterolaemia (FH): prevalence and implications for FH clinical diagnosis
by: A. David, et al.
Published: (2023-12-01)

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): a study comparing FH individuals in UK primary care and the UK Simon Broome register linked with secondary care records
by: B. Iyen, et al.
Published: (2022-10-01)

Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
by: Pier Luigi Temporelli, et al.
Published: (2021-02-01)

Lomitapide, a cholesterol-lowering drug, is an anticancer agent that induces autophagic cell death via inhibiting mTOR
by: Boah Lee, et al.
Published: (2022-07-01)

The Succinated Proteome of FH-Mutant Tumours.
by: Yang, M, et al.
Published: (2014)

The Succinated Proteome of FH-Mutant Tumours
by: Ming Yang, et al.
Published: (2014-08-01)

A comparative sequence analysis reveals a common GBD/FH3-FH1-FH2-DAD architecture in formins from <it>Dictyostelium</it>, fungi and metazoa
by: Uyeda Taro QP, et al.
Published: (2005-03-01)

El género Agaricus L. : Fr. - Agaricus luteomaculatus (F.H. Möller) F.H. Möller.
by: ARRILLAGA, P., LASKIBAR, X.
Published: (2002-01-01)

F.H. Bradley as theological utilitarian
by: Crisp, R
Published: (2021)

Adaptive FH-SVM for Imbalanced Classification
by: Qi Wang, et al.
Published: (2019-01-01)

Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
by: Lakshmi Lavanya Reddy, et al.
Published: (2022-01-01)

Repositioning Lomitapide to block ZDHHC5-dependant palmitoylation on SSTR5 leads to anti-proliferation effect in preclinical pancreatic cancer models
by: Yumeng Wang, et al.
Published: (2023-02-01)

The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
by: Michelle M. Schreuder, et al.
Published: (2021-11-01)

Human Factor H (FH) Impairs Protective Meningococcal Anti-FHbp Antibody Responses and the Antibodies Enhance FH Binding
by: Isabella Costa, et al.
Published: (2014-10-01)

Does socioeconomic status have an effect on the treatment and outcomes of individuals with familial hypercholesterolaemia (FH)? : a cohort study of individuals with FH in UK primary care
by: B. Iyen, et al.
Published: (2021-09-01)

15 Jahre Weiterbildung an der FH Erfurt
by: Brit Arnold
Published: (2020-09-01)

Mechanisms of FH Protection Against Neovascular AMD
by: Céline Borras, et al.
Published: (2020-04-01)

The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway
by: Simone Bini, et al.
Published: (2022-04-01)

FH deficient uterine leiomyomas-a case series
by: Meenakshi Kamboj, et al.
Published: (2024-01-01)

Social Media zur Förderung der FH-Forschung
by: Heinrich Stülpnagel
Published: (2012-03-01)

The Contribution of the Chemical Industry and the 'Chemiker FH' to the Swiss Economy
by: Christof Jud
Published: (2003-01-01)

The Genetic Spectrum of Familial Hypercholesterolemia (FH) in the Iranian Population
by: R. H. Fairoozy, et al.
Published: (2017-12-01)

FH535 inhibited migration and growth of breast cancer cells.
by: Joji Iida, et al.
Published: (2012-01-01)

IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR "SCORE" TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)
by: Descamps, O, et al.
Published: (2010)

Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
by: Ingunn Molven, et al.
Published: (2013-01-01)

Novel insights into FH-associated disease are KEAPing the lid on oncogenic HIF signalling.
by: Adam, J, et al.
Published: (2011)